French Medical Lab Chooses VAST's Universal Storage Data Platform for Genome Analysis

French Medical Lab Chooses VAST’s Universal Storage Data Platform for Genome Analysis

NEW YORK, September 21, 2022 VAST Data announced today that the French medical biology laboratory specializing in genomic medicine, SeqOIA (Sequencing Omics Information Analysis Cooperative Health Group), has selected VAST’s all-flash universal storage data platform to accelerate and optimize the analysis of genetic data for medical diagnostic purposes.

VAST Data’s all-flash data platform replaces SeqOIA’s previous hard-disk storage solution, which hit performance limits on all large genetic datasets, resulting in wasted time and analysis . Since going live with the VAST platform in March 2022, SeqOIA has accelerated genome analysis time by 4X.

“In terms of managing our production, it has changed our lives. In our industry, wasted time equates to wasted scans and patients getting no return,” says Alban Lermine, Director of Information Systems and Bioinformatics at SeqOIA. Additionally, after partnering with VAST, the SeqOIA lab has eliminated attempts to read and write unresolved data, reducing errors to prevent missing or delayed results for patients.

“VAST’s flexible architecture allows us to choose to seamlessly scale computing and storage capacity entirely independently, which is complicated with other solutions on the market,” said Lermine. “As we look to the future, we plan to launch other treatment methods designed to discover rare diseases and cancers. As we evolve, each new pipeline will require more I/O, but not necessarily more storage volume. This is clearly an advantage of using VAST, we are able to design a system where there is no “unnecessary storage” in our infrastructure. »

Additionally, SeqOIA can now realize the vision of an all-flash storage infrastructure without incurring exorbitant costs. The unique similarity-based data reduction techniques of VAST’s Universal Storage data platform allow SeqOIA to double the data volume without spending more on storage. For example, the lab uses 16 terabytes (TB) of Elastic Search indexes, at the cost of just 8 TB of universal storage.

“With the operation of the SeqOIA lab in France, we are proving the seamless performance and flexible scalability features of our universal storage architecture for the data-intensive healthcare industry,” said Vincent Gibert, Regional Director SEUR from VAST Data.

For Lermine, VAST is not just cutting-edge technology. Expert customer service was another reason to choose VAST. VAST’s local team provides ‘hands-on’ support and its global co-pilot program proactively monitors operations and mitigates issues should they arise. “VAST is truly dedicated to our success; it really feels like the services and support team is an extension of the SeqOIA IT team,” he concluded.

Thanks to whole genome sequencing, SeqOIA looks for different types of genetic events (point mutations, insertions/deletions, fusions, copy number variations, etc.) in patients to better characterize pathologies and thus offer genetic counseling to families. or a new line of treatment. As part of the France Genomic Medicine Plan 2025, SeqOIA is one of the two national laboratories integrating whole genome sequencing into the French health system, for the benefit of patients with cancer and rare diseases. The lab has sequenced more than 20,000 genomes since 2019.

About VAST data

VAST Data’s managed storage software unlocks the value of data and modernizes data centers for the age of AI computing. VAST delivers real-time performance for all data and overcomes historical cost barriers associated with building all-flash data centers. Since its launch in February 2019, VAST has become the best-selling infrastructure startup in history. For more information, please visit https://vastdata.com.


Source: VAST Data

#French #Medical #Lab #Chooses #VASTs #Universal #Storage #Data #Platform #Genome #Analysis

Leave a Comment

Your email address will not be published.